The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 345:133-134 July 12, 2001 Number 2
NextNext

Doxycycline for Tick Bites — Not for Everyone

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Nadelman, R. B.
-PubMed Citation
Recently, a panel of experts of the Infectious Diseases Society of America recommended that persons bitten by deer ticks (Ixodes scapularis) should not routinely receive antimicrobial chemoprophylaxis.1 This recommendation was based on an assessment of the risks and the consequences of Lyme disease, as well as the costs, adverse effects, and efficacy of antimicrobial prophylaxis. Should those recommendations change after the report in this issue of the Journal by Nadelman et al. of a well-designed trial in which a single dose of doxycycline was 87 percent effective in preventing Lyme disease?2

The results of the study confirm that . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.